Adjuvant Radiotherapy for Surgically Resected Stage III Merkel Cell Carcinoma
JAMA Surgery · 01.03.2024 · 159 (3) · 347
DOI: 10.1001/jamasurg.2023.7016 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Surgery, erschienen am 01.03.2024. Verfasst von Seyed Saeed Pairawan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Loma Linda University Health, Loma Linda, California. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This case-control study evaluates whether adjuvant radiotherapy is associated with overall survival among patients with surgically resected stage III Merkel cell carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Loma Linda University Health, Loma Linda, California.
- Department of Surgery, Swedish Medical Center, Seattle, Washington.
Zitieren
APA
Pairawan, S. S., Dominguez, C. E., Solomon, N., Caba-Molina, D., O'Leary, M., Reeves, M. E., & Namm, J. P. (2024). Adjuvant Radiotherapy for Surgically Resected Stage III Merkel Cell Carcinoma. JAMA Surgery, 159(3), 347. https://doi.org/10.1001/jamasurg.2023.7016
Vancouver
Pairawan SS, Dominguez CE, Solomon N, Caba-Molina D, O'Leary M, Reeves ME, et al. Adjuvant Radiotherapy for Surgically Resected Stage III Merkel Cell Carcinoma. JAMA Surgery. 2024;159(3):347. doi:10.1001/jamasurg.2023.7016
BibTeX
@article{Pairawan2024,
author = {Pairawan, Seyed Saeed and Dominguez, Chloe E and Solomon, Naveenraj and Caba-Molina, David and O'Leary, Michael and Reeves, Mark E and Namm, Jukes P},
title = {Adjuvant Radiotherapy for Surgically Resected Stage III Merkel Cell Carcinoma},
journal = {JAMA Surgery},
year = {2024},
volume = {159},
number = {3},
pages = {347},
doi = {10.1001/jamasurg.2023.7016}
}
EUVIMED